protein (gpl20) in the viral envelope. 4 During the first few weeks of treatment with zidovudine platelet counts rose in both patients with thrombocytopenia and those with normal counts. This suggests that reticuloendothelial inhibition may not be the only mechanism.
The eventual fall in platelet count with longer treatment probably had several causes, but the only significant association in our patients was with the development of probable myelotoxicity due to zidovudine, suggesting that this was the cause. We found no easily identifiable variables before treatment, other than a low platelet count, that predicted a good eventual response.
Current treatments for thrombocytopenia related to HIV infection have potential disadvantages-namely, immunosuppression from steroids and splenectomy with consequent risk of progression of the disease, problems of availability of high dose immunoglobulins, and lack of access to veins, especially in intravenous drug users. Zidovudine may be a useful alternative for symptomatic thrombocytopenia. The good response among those with even severe thrombocytopenia shows that this should not be considered a contraindication to treatment. Cigarette smokers on average drink more coffee than non-smokers and can metabolise caffeine much more rapidly.' 2 One possible explanation for their increased consumption is that smokers need to drink more coffee to achieve the desired concentrations of caffeine in the body and hence the desired effects. When smokers stop smoking the rate at which caffeine is metabolised declines. If consumption of caffeine remains the same concentrations of caffeine in the body should rise. Persistent increases in caffeine concentrations may cause concern in view of recent data showing an increased risk of coronary heart disease in and low birth weight of children of heavy coffee drinkers.3 4 We studied plasma caffeine concentrations and caffeine consumption before and for six months after subjects gave up smoking.
Subjects, methods, and results
Ninety five healthy subjects were recruited for a stop smoking programme.' The subjects' average age was 38 (range 19-60); 38 were men, 87 were white, and almost all were middle or working class. Subjects were Mean (SD) caffeine consumption and plasma caffeine and cotinine concentrations in subjects who had stopped smoking for 12 and 26 weeks and in those who continued smoking. assessed before entry to the programme and 12 and 26 weeks afterwards. Assessment included analysis of plasma samples for cotinine (a primary metabolite of nicotine used to indicate nicotine intake) and caffeine concentrations, body weight, and a three day record of weighed food intake. Sixty eight subjects completed the study. Data were available on 64 subjects at 12 weeks and 61 subjects at 26 weeks. The subjects who subsequently continued smoking were significantly older (mean 42-8 v 36-2 years) but cigarette consumption, numbers of years of smoking, and plasma cotinine and caffeine concentrations were not significantly different between those who gave up and those who continued smoking. At 12 and 26 weeks plasma caffeine concentrations in subjects who stopped smoking were more than double the baseline value (table). Caffeine concentrations in smokers changed little throughout the study. Subjects who stopped smoking had significantly decreased their caffeine consumption at 26 weeks.
Comment
Our study confirms the hypotheses that plasma caffeine concentrations increase after people give up smoking and remain increased for at least six months. This increase was substantial, averaging more than 250%. In subjects who continued to smoke caffeine concentrations were unchanged, as expected.
The average caffeine concentration in the body is determined by the consumption and rate of metabolism of caffeine. Consumption was either unchanged (at 12 weeks) or decreased (at 26 weeks) in subjects who stopped smoking. Thus the increased caffeine concentrations were the result of slowed metabolism due to abstinence from tobacco. Caffeine consumption was significantly decreased at 26 weeks, which is consistent with a degree of self regulation of caffeine concentrations. Regulation of caffeine concentrations could explain why cigarette smokers drink more coffee. As they metabolise caffeine more quickly, the half life of caffeine is shorter and the desired effects of the caffeine disappear or symptoms of withdrawal appear more quickly. Smokers would need to drink coffee more frequently to maintain caffeine concentrations similar to those in non-smokers. The rate of metabolism of caffeine decreases within three or four days after a subject stops smoking. Assuming that consumption of caffeine is unchanged, high caffeine concentrations could contribute to the tobacco withdrawl syndrome.
An increase of 250% in caffeine concentrations is equivalent to drinking two and a half times as many cups of coffee or tea each day as usual. If there is a dose response relation between coffee consumption and coronary heart disease or low birthweight babies, as seems to be the case, and that risk is mediated by caffeine then smokers who abstain would be at continuing high risk because of their caffeine consumption. Doctors 4 We studied this and whether affected children might be identified without recourse to studies during sleep.
Subjects, methods, and results Forty four children (aged 2 to 7) were studied on the night before adenotonsillectomy. Twenty controls with no active symptoms of upper or lower respiratory tract disease were studied on the night before another elective procedure. Both groups underwent a preoperative clinical assessment by an otorhinolaryngologist, who noted symptoms, signs, and the indication for adenotonsillectomy.
Oxygen saturation was measured continuously overnight with a pulse oximeter (Novametrix). Chest impedance was also measured and electrocardiography performed. The Hypoxic patients could not be identified by clinical features alone, but by combining the presence or absence of breathing through the mouth with the oxygen saturation when awake we identified affected patients with 93% sensitivity (95% confidence interval 70 to 100%) and 86% specificity (73 to 99%).
We showed that significant night time hypoxaemia is common, occurring in 34% of children admitted for adenotonsillectomy. We have clearly defined the importance of breathing through the mouth as a clinical sign of obstruction and the usefulness of measuring oxygen saturation when awake. Children who clearly breath through the mouth will suffer night time hypoxaemia unless their oxygen saturation when awake is at least 97%. We hope that this will help paediatricians and otorhinolaryngologists to assess children correctly and avoid unnecessary operations.
